BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9510171)

  • 1. Activation requirements, lytic mechanism, and development of a novel anti-CD8-resistant CTL population.
    McCarthy SA; Mainwaring MS; Dougall DS; Lamouse-Smith ES
    J Immunol; 1998 Mar; 160(6):2715-24. PubMed ID: 9510171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of anti-CD8-resistant cytolytic T lymphocytes induced by multivalent cross-linking of CD8 on precursor cells.
    McCarthy SA; Kaldjian E; Singer A
    J Immunol; 1989 Oct; 143(7):2112-9. PubMed ID: 2528588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine requirements for production of a novel anti-CD8-resistant CTL population.
    Lamousé-Smith ES; Dougall DS; McCarthy SA
    J Immunol; 1999 Oct; 163(8):4160-7. PubMed ID: 10510351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of anti-CD8 resistant cytotoxic T lymphocytes by anti-CD8 antibodies. Functional evidence for T cell signaling induced by multi-valent cross-linking of CD8 on precursor cells.
    McCarthy SA; Kaldjian E; Singer A
    J Immunol; 1988 Dec; 141(11):3737-46. PubMed ID: 2972777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and regeneration of a novel anti-CD8-resistant cytolytic T lymphocyte population.
    Dougall DS; Lamousé-Smith ES; McCarthy SA
    Cell Immunol; 2000 Oct; 205(1):1-12. PubMed ID: 11078602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allospecific cytotoxic T cells generated from beta 2m-/- mice in primary MLC: analysis of activation requirements, specificity, and phenotype.
    Lamousé-Smith E; McCarthy SA
    Cell Immunol; 1997 Aug; 179(2):107-15. PubMed ID: 9268494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epithelial cell-specific integrin, CD103 (alpha E integrin), defines a novel subset of alloreactive CD8+ CTL.
    Hadley GA; Bartlett ST; Via CS; Rostapshova EA; Moainie S
    J Immunol; 1997 Oct; 159(8):3748-56. PubMed ID: 9378961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immobilized anti-TCR mAb induces split functions in a CD8+ CTL clone.
    Kuwano K; Ono S; Arai S
    Cell Immunol; 1994 Jan; 153(1):105-16. PubMed ID: 8287485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloreactive T cells that do not require TCR and CD8 coengagement are present in naive mice and contribute to graft rejection.
    Smith PA; Potter TA
    J Immunol; 1998 Jun; 160(11):5382-9. PubMed ID: 9605138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of T cell subsets in the generation of secondary cytolytic responses in vitro against class I and class II major histocompatibility complex antigens.
    Vidović D; Klein J; Nagy ZA
    J Immunol; 1984 Mar; 132(3):1113-7. PubMed ID: 6229577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic T lymphocyte-induced loss of target cell adhesion and lysis involve common and separate signaling pathways.
    Abrams SI; McCulley DE; Meleedy-Rey P; Russell JH
    J Immunol; 1989 Mar; 142(6):1789-96. PubMed ID: 2784138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic characterization of the post-thymic differentiation of human alloantigen-specific CD8+ cytotoxic T lymphocytes.
    Yamashita N; Clement LT
    J Immunol; 1989 Sep; 143(5):1518-23. PubMed ID: 2474603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CD8 in staphylococcal enterotoxin B-mediated lysis by cytotoxic T lymphocytes.
    Hoo WS; Kranz DM
    J Immunol; 1993 May; 150(10):4331-7. PubMed ID: 8482838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous mechanisms of human cytotoxic T lymphocyte generation. II. Differential effects of IL-6 on the helper cell-independent generation of CTL from CD8+ precursor subpopulations.
    Bass HZ; Yamashita N; Clement LT
    J Immunol; 1993 Sep; 151(6):2895-903. PubMed ID: 8376760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal anti-Lyt-2 antibodies block the activation of cytolytic T lymphocyte precursors.
    Glasebrook AL; MacDonald HR
    J Immunol; 1983 Apr; 130(4):1552-5. PubMed ID: 6220055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
    Riquelme E; Carreño LJ; González PA; Kalergis AM
    Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12.
    Okamoto I; Kohno K; Tanimoto T; Ikegami H; Kurimoto M
    J Immunol; 1999 Mar; 162(6):3202-11. PubMed ID: 10092771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of CTL antipeptide response mediated by CD8+ cells whose class I MHC can bind the peptide.
    Sambhara SR; Miller RG
    J Immunol; 1994 Feb; 152(3):1103-9. PubMed ID: 8301119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
    Waeckerle-Men Y; Starke A; Wüthrich RP
    Nephrol Dial Transplant; 2007 Jun; 22(6):1527-36. PubMed ID: 17339272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theiler's virus infection of genetically susceptible mice induces central nervous system-infiltrating CTLs with no apparent viral or major myelin antigenic specificity.
    Lin X; Pease LR; Murray PD; Rodriguez M
    J Immunol; 1998 Jun; 160(11):5661-8. PubMed ID: 9605173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.